SCHEMBL14232256

SCHEMBL14232256

O=C(CN1CCOCC1)NCCOc1ccc2c(c1)CNC2

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.49
HRH3 Q9Y5N1 1/20 0.47
POLB P06746 1/20 0.46
KMT2A Q03164 3/20 0.46
MEN1 O00255 1/20 0.46
CYP3A4 P08684 1/20 0.46
TSHR P16473 1/20 0.46
CYP2C19 P33261 1/20 0.46
ALDH1A1 P00352 4/20 0.46
HPGD P15428 2/20 0.46
ALOX15 P16050 1/20 0.46
MTNR1A P48039 1/20 0.46
MTNR1B P49286 1/20 0.46
MAPK1 P28482 2/20 0.44
HBB P68871 1/20 0.44
USP2 O75604 1/20 0.44
HTT P42858 1/20 0.44
HSD17B10 Q99714 1/20 0.43
MAPT P10636 1/20 0.42
KDM4E B2RXH2 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12853724 0.84 POLB (0.50) SMN1; SMN2HRH3POLBKMT2AMEN1
SCHEMBL329891 0.79 HRH3 (0.63) HRH3KMT2AMEN1TSHRALDH1A1
SCHEMBL29640958 0.79 HRH3 (0.63) HRH3KMT2AMEN1TSHRALDH1A1
SCHEMBL329515 0.78 HRH3 (0.73) HRH3ALDH1A1MAPK1USP2KDM4E
Hydrochloric Acid SCHEMBL31014160 0.78 HRH3 (0.62) HRH3KMT2AMEN1ALDH1A1MAPK1
SCHEMBL329593 0.75 SMN1; SMN2 (0.48) SMN1; SMN2HRH3POLBKMT2AMEN1
SCHEMBL10214800 0.73 HSP90AA1 (0.51) ABHD6
SCHEMBL4067628 0.71 HSP90AA1 (0.41) HRH3ALDH1A1HPGDALOX15MTNR1A
SCHEMBL17937106 0.69 SMN1; SMN2 (0.72) SMN1; SMN2POLBKMT2AMEN1CYP3A4
SCHEMBL19249460 0.68 CA1 (0.59) POLBCYP2C19KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9914719-B2 Hydroxybenzamide derivatives and their use as inhibitors of HSP90 ASTEX THERAPEUTICS LTD. (GB) 2018-03-13 US disclosed
US-9730912-B2 Pharmaceutical compounds ASTEX THERAPEUTICS LIMITED (GB) 2017-08-15 US disclosed
WO-2008044029-A1 PHARMACEUTICAL COMBINATIONS ASTEX THERAPEUTICS LIMITED (GB) 2008-04-17 WO disclosed